Theraly Pharmaceuticals

company

About

A product focused pharmaceutical company.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$200K
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Theraly is a product focused pharmaceutical company with a goal to efficiently generate medically important, stable, and long-acting therapies. Theraly enables products using its proprietary platform technology that can empower short-acting peptides and proteins by dramatically increasing their half-lives while maintaining potency. Their lead program is a preclinical stage product in development for organ fibrosis. TLY012, has shown therapeutic efficacy in a number of pre-clinical models of organ fibrosis, autoimmune/inflammatory conditions, and in oncology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$200K
Theraly Pharmaceuticals has raised a total of $200K in funding over 2 rounds. Their latest funding was raised on Mar 21, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 21, 2018 Seed $200K 1 TEDCO Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Theraly Pharmaceuticals is funded by 1 investors. TEDCO are the most recent investors.
Investor Name Lead Investor Funding Round
TEDCO Yes Seed